The Cooper Companies, Inc.
Health
Performance
5.0
Risk
Sell
Buy
Curious about the Scores? Learn more.

The Cooper Companies, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

20.12.2025
On shaky ground. Struggling to find a clear direction.
09.12.2025
Risk creeping up. Stability not bulletproof anymore.
23.08.2025
Stability slipping. Financial grip’s not as firm as it was.

The Cooper Companies, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does The Cooper Companies, Inc. do? Business model and key facts

Get the full picture of The Cooper Companies, Inc.: what it builds, where it operates, and how it makes money.

The Cooper Companies, Inc. Profile

Sector: Healthcare

Industry: Medical - Instruments & Supplies

Employees (FY): 16000

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

shop
Company facts
Albert G. White
CEO
16000
Employees worldwide
shop
Performance
-9.23%
Last 12 months
-12.64%
Last 5 years
shop
Growth
$3,90B
Revenue year
$392,30M
Net income
shop
Valuation
$16,39B
Market Cap
53.07
Price/Earnings Ratio

Stocks related to The Cooper Companies, Inc.

Selected based on industry alignment and relative market positioning.

HOLX
Hologic, Inc.
75.02
-0.19%
3.4
Sell
Buy
Hologic, Inc.
WST
West Pharmaceutical Services, Inc.
279.41
+1.61%
6.3
Sell
Buy
West Pharmaceutical Services, Inc.
RMD
ResMed Inc.
260.70
+0.46%
4.5
Sell
Buy
ResMed Inc.
BAX
Baxter International Inc.
20.37
+2.67%
6.9
Sell
Buy
Baxter International Inc.
RGEN
Repligen Corporation
161.69
-0.21%
6.6
Sell
Buy
Repligen Corporation

The Cooper Companies, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.